Investor Type | Firm |
Type of Fund | VC |
Industries | Software (Web Marketplace Saas..) • Other • IT (& TMT) • BioTech • Businesses Solutions • Hardware (& Manufacturing) • Energy • CleanTech • HealthTech (& Fitness) • Food & Beverage • Material Science • Aerospace (& Defense) |
Stages | Early,Seed,Later, Series A |
Investing | France |
Investment Range | $2,000,000 - $20,000,000 |
Naxicap Partners is a prominent private equity firm based in France that specializes in various investment strategies including management buyouts, management buy-ins, leveraged buyouts, recapitalizations, turnarounds, seed financing, early stage, and later stage investments. The firm primarily targets French companies but also extends its operations to entities in the Benelux, Germany, and Spain, accounting for approximately 25% of their investment activity. Historically, Naxicap Partners has focused on minority stakes in the Capital Development sector, but over time it has evolved to predominantly engage in majority LBO transactions which now constitute over 80% of their deals. Naxicap prefers to invest in stable B2B companies with understandable business models, ensuring balanced use of leverage to support companies' growth. Their current strategy is centered around investing in growth companies or projects with a significant build-up component. They invest in sectors such as business services, consumer goods, healthcare, IT and computing, real estate, textiles, equipment, personal services, food processing, and communications. Naxicap operates as a subsidiary of Natixis Private Equity and prides itself on providing regular and durable performance to their investors, with emphasis on growth and capital development. With an investment range of €2 million to €20 million, they aim to be a majority shareholder offering ticket sizes between €50 million to €200 million, and typically hold investments for a period of 5 to 7 years. Naxicap Partners also incorporates ESG considerations into their investment process, focusing on innovation and growth, with a portfolio that includes sectors such as real estate, industry, B2B services and software, and biotech and health. Over the past 15 years, their assets under management have increased twelve-fold, reflecting their successful investment approach and commitment to the growth of small and medium-sized enterprises (SMEs) and mid-cap companies.